Pharmaceutical Technology7 小时
EXO-CD24 by Nano24med for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
EXO-CD24 is under clinical development by Nano24med and currently in Phase II for Coronavirus Disease 2019 (COVID-19).